Skip to content

Safety and Efficacy of “Artificial Aqueous Misdirection“ in Preventing LIDRS During Phacoemulsification Surgery for High Myopic Cataract

Safety and Efficacy of “Artificial Aqueous Misdirection“ in Preventing LIDRS During Phacoemulsification Surgery for High Myopic Cataract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126631
Enrollment
Unknown
Registered
2026-06-12
Start date
2026-06-17
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

LIDRS

Interventions

Active Fluid Injection Group:Controlled active fluid injection posterior to the iris
Non-fluid Injection Group:conventional phacoemulsification surgery

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged >=18 years, with no gender restriction; 2. Meet the diagnostic criteria for high myopia: axial length >= 26 mm, spherical equivalent <= -6.00 D; 3. Patients with cataract who are scheduled to undergo transparent corneal incision phacoemulsification combined with posterior chamber intraocular lens implantation; 4. If both eyes meet the study criteria, only the eye undergoing the first surgery will be included; 5. Participants are able to communicate effectively with the researchers, understand the study, and voluntarily sign a written informed consent form; 6. Willing and able to attend all scheduled visits and assessments.

Exclusion criteria

Exclusion criteria: 1.Eye pain score in the study eye during the screening period was greater than "0" (NRS score). 2.The fellow eye had undergone cataract surgery. 3.The study eye has active disease or a history of chronic or recurrent inflammatory eye diseases (e.g., iritis, scleritis, uveitis, iridocyclitis, rubeosis iridis). 4.Evidence of acute external or intraocular infection in the study eye. 5.Participants with any of the following fundus lesions: severe macular lesions such as macular edema, proliferative diabetic retinopathy, retinal detachment, or other severe fundus diseases. 6.History of intraocular surgery or ocular trauma in the study eye, or planning to undergo any ocular surgery (except cataract surgery) during the study. 7.Preoperative examinations indicate lens dislocation or subluxation. 8. Any subjects with glaucoma, high eye pressure, or currently receiving glaucoma medication

Design outcomes

Primary

MeasureTime frame
The incidence of LIDRS;

Secondary

MeasureTime frame
Time for key steps during surgery;Intraoperative pain NRS score;

Countries

China

Contacts

Public ContactJin Li

Eye Hospital, Wenzhou Medical University

lijin_wz@163.com+86 577 8806 8822

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026